COVID-19 Not Over: 45 Death Reported in September In China

News

COVID-19 Not Over: 45 Death Reported in September In China

COVID-19 Not Over: 45 Death Reported in September In China

In September, 45 new locally transmitted COVID-19 death cases reported in China. China National Health Commission: 398 New Severe Cases of COVID-19 in September.

The latest update from the Chinese Center for Disease Control and Prevention includes a report on the national situation of severe COVID-19 infections and deaths from September 1 to 30.

During this period, all 31 provinces, autonomous regions, municipalities, and the Xinjiang Production and Construction Corps reported 398 new severe cases and 45 new deaths.

Among the fatalities, one was attributed to respiratory failure caused by COVID-19 infection, while the remaining 44 were cases in which underlying health conditions were exacerbated by COVID-19.

The number of patients seeking treatment at fever clinics across China’s 31 provinces, autonomous regions, municipalities, and the Xinjiang Production and Construction Corps fluctuated throughout September. It increased from 116,000 on September 1, reached a recent peak of 177,000 on September 18, and then gradually declined to 141,000 on September 30.

The positivity rate for COVID-19 in influenza-like cases also showed a decrease from 18.6% in the 35th week of 2023 to 10.5% in the 39th week.

From September 1 to 30, a total of 11,629 locally transmitted COVID-19 cases had their viral genomes sequenced, and all were identified as Omicron variant strains. These cases covered 96 different evolutionary branches, with the primary circulating variants being the XBB series, including XBB.1.9 and its subbranches, XBB.1.22 and its subbranches, and XBB.1.16 and its subbranches.

Based on the sampling date, the prevalence of XBB and its subbranches remained consistently high, at 99.7% in the 35th week (August 28 to September 3), 99.8% from the 36th to 38th weeks, and 100.0% in the 39th week (September 25 to October 1).

COVID-19 Not Over: 45 Death Reported in September In China

Since the easing of pandemic restrictions, a significant number of individuals have contracted the COVID-19 virus. Simultaneously, cases of tachycardia (rapid heartbeat) and anxiety disorders have been on the rise.

According to the latest global data, over 150 million people have been infected with the COVID-19 virus, and approximately 30% of those who recover from the virus subsequently experience symptoms of tachycardia and anxiety.

Tachycardia refers to a resting heart rate exceeding 100 beats per minute, and most individuals experiencing this condition had no prior heart issues. Some speculate that this may be due to inflammatory responses and abnormal immune system activation triggered by COVID-19 infection, leading to compromised heart function.

Moreover, anxiety disorders have also shown a noticeable increase among post-COVID-19 patients. Around 20% of those who have recovered report various physical manifestations of anxiety, such as insomnia, palpitations, and fatigue. While these symptoms strongly suggest a connection to COVID-19 infection, there is currently no definitive scientific evidence to confirm this theory.

Regardless of the future course of the pandemic, it is essential not to dismiss information related to COVID-19. Understanding the trajectory of the virus can aid in better disease prevention.